The Australian Medical Association Limited and state AMA entities comply with the Privacy Act 1988. Please refer to the AMA Privacy Policy to understand our commitment to you and information on how we store and protect your data.

×

Search

×

Banner - GPNN Issue 16 Number 6


Tile - GPNN Issue 16 Number 6


18 Feb 2016

Last week the AMA convened its second meeting of medical profession leaders to discuss the progress of, and concerns about, the MBS Review.

AMA President Professor Brian Owler said all in attendance wanted to achieve an MBS that reflected modern medical practice, and which benefited patients, but warned delays in listing new MBS items to replace scrapped items could create an incomplete Schedule, with serious implications for patient care.


Published: 18 Feb 2016

18 Feb 2016

The Department of Human Services (DHS) has written to the AMA regarding the current unacceptable delays in processing applications for Medicare provider numbers. The AMA is concerned at these delays, which further reinforce the need for a single provider number as proposed by the AMA.


Published: 18 Feb 2016

18 Feb 2016

AMA President, Professor Brian Owler, will this week travel to the Northern Territory to meet doctors and other health workers in Alice Springs, and visit a number of remote Indigenous communities to see first-hand how health services are being delivered at the local level.

In the wake of last week’s Closing the Gap report, which showed that key health and education targets are not being met, Professor Owler will use the visit to observe frontline experiences to inform AMA policy and advocacy on Indigenous health issues.


Published: 18 Feb 2016

18 Feb 2016

In his first Australian Medicine column for 2016, AMA Council of General Practice Chair, Dr Brian Morton, writes about the uncertainties for general practice in the coming year in the face of an ongoing rebate freeze and potential reforms arising from the Primary Health Care Advisory Group Review.


Published: 18 Feb 2016

18 Feb 2016

A number of new medicines will be made available through the Pharmaceutical Benefits Scheme (PBS) from 1 March 2016 for the treatment of all adult patients with chronic hepatitis C infection. GPs will be able to prescribe these medicines in, or following, consultation with a specialist physician.

This prescribing flexibility has been introduced to facilitate a greater role for primary care in the treatment of hepatitis C over time.


Published: 18 Feb 2016